This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
Despite the abundant educational programs from pharmaceutical houses, the physician often wishes for an impartial evaluation of new agents with a comparison to medicines already available. The blight of "falling behind times" is the most-feared malady facing the modern practitioner. Dr. Modell, along with 46 similarly distinguished collaborators, has formulated a solution to such perplexities in a very readable book.
This is the second biannual revision. There are an insufficient number of new drugs to require more frequent publication, yet a longer period would invite obsolescence. The contributors rely on actual clinical experience gained in their own practices. Recent additions to the pharmacopeia are included, but approval depends on substantiation. This is in no way a criticism, of course.
Each chapter deals with a broad and important phase of practice. Although the greater portion of the book deals with comparisons of members of large, related families of drugs ( antibacterials, tranquilizers,
Martin HB. Drugs of Choice 1962-1963. JAMA. 1962;182(1):97. doi:10.1001/jama.1962.03050400099032
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: